Obadiah J. Plante

Nessuna posizione attualmente

Consumer Services

Health Technology

Finance

Profilo

Dr. Obadiah J.
Plante is Senior Director-Discovery Research at Synglyco, Inc. He received his undergraduate degree from Worcester Polytechnic Institute, a graduate degree from Columbia University, and a doctorate degree from the Massachusetts Institute of Technology.

Precedenti posizioni note di Obadiah J. Plante

Società	Posizione	Fine
Synglyco, Inc. Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Synglyco, Inc. develops novel vaccines using synthetic carbohydrates. The firm's cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications. Its proprietary platform generates significant quantities of chemically pure, complex carbohydrates through automated and manual chemical synthesis. The company was founded by Peter H. Seeberger, Carmichael S. Roberts Jr. Obadiah J. Plante and Louis Schofield on June 18, 2001 and is headquartered in New York, NY.	Fondatore	-

Vedi nel dettaglio l'esperienza di Obadiah J. Plante

Formazione di Obadiah J. Plante

Worcester Polytechnic Institute	Undergraduate Degree
The Trustees of Columbia University in The City of New York	Graduate Degree
Massachusetts Institute of Technology	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Obadiah J. Plante

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Synglyco, Inc. Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Synglyco, Inc. develops novel vaccines using synthetic carbohydrates. The firm's cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications. Its proprietary platform generates significant quantities of chemically pure, complex carbohydrates through automated and manual chemical synthesis. The company was founded by Peter H. Seeberger, Carmichael S. Roberts Jr. Obadiah J. Plante and Louis Schofield on June 18, 2001 and is headquartered in New York, NY.	Health Technology